Literature DB >> 29913164

Structural and visual functional deficits in a rat model of neuromyelitis optica spectrum disorders related optic neuritis.

Yuxin Zhang1, Yiqin Bao2, Wei Qiu3, Lisheng Peng3, Ling Fang3, Ying Xu4, Hui Yang5.   

Abstract

Neuromyelitis optica spectrum disorders (NMOSD) are a group of autoimmune astrocytopathies in the central nervous system, which are mainly caused by immunoglobulin G (IgG) against astrocyte water channel aquaporin-4 (AQP4). In this study, we aimed to establish a model of NMOSD-related optic neuritis (NMOSD-ON) and to evaluate the progressive changes of the optic nerve and visual function. AQP4 IgG-positive serum from NMOSD patients was injected into the subarachnoid space of the rat optic nerve to induce the NMOSD-ON model (AQP4 + group), and healthy serum was injected as the control. The visual evoked potential, pupillary light reflex and optical coherence tomography were monitored every week for 3 weeks after induction. Compared with the control group, the amplitude of the N1-P1 peak and pupillary light reflex in the AQP4+ group were reduced within the first week and then remained low thereafter. Consistent with the functional deficits, the thickness of the peripapillary retinal nerve fiber layer in the AQP4 + group was also greatly reduced. At the end of 3 weeks, there was a loss of retinal ganglion cells and the optic nerves showed characteristic NMOSD-like pathologic changes, including deposition of AQP4 IgG, local astrocyte damage, demyelination, microglia activation, macrophage infiltration and axonal injury. Thus, we have established an NMOSD-ON rat model with deficits in the optic nerve and visual function that may be a valuable tool for exploring the mechanism of NMOSD-ON and evaluating its potential therapeutic treatment.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AQP4 IgG; Neuromyelitis optica spectrum disorders; Optic neuritis; Optical coherence tomography; Pupillary light reflex; Visual evoked potential

Mesh:

Substances:

Year:  2018        PMID: 29913164     DOI: 10.1016/j.exer.2018.06.011

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  6 in total

1.  Effects of C5a and Receptor CD88 on Glutamate and N-Methyl-D-Aspartic Acid Receptor Expression in the Mouse Model of Optic Neuromyelitis.

Authors:  Ling Li; Jiangwei Tang; Hongxin Wang; Jiamei Liu; Lina Zhou
Journal:  Comput Math Methods Med       Date:  2022-04-25       Impact factor: 2.809

2.  Progressive Retinal and Optic Nerve Damage in a Mouse Model of Spontaneous Opticospinal Encephalomyelitis.

Authors:  Laura Petrikowski; Sabrina Reinehr; Steffen Haupeltshofer; Leonie Deppe; Florian Graz; Ingo Kleiter; H Burkhard Dick; Ralf Gold; Simon Faissner; Stephanie C Joachim
Journal:  Front Immunol       Date:  2022-01-24       Impact factor: 7.561

3.  Magnetic Resonance Image in Monitor and Diagnosis of Patients with Neuromyelitis Optica.

Authors:  Shujuan Lu; Dongming Wang; Fengxian Zhang; Meilan Liu
Journal:  Contrast Media Mol Imaging       Date:  2022-03-17       Impact factor: 3.161

Review 4.  Experimental animal models of aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress and shortcomings.

Authors:  Tianjiao Duan; Alan S Verkman
Journal:  Brain Pathol       Date:  2019-10-21       Impact factor: 6.508

Review 5.  The Emerging Role of Microglia in Neuromyelitis Optica.

Authors:  Tingjun Chen; Dale B Bosco; Yanlu Ying; Dai-Shi Tian; Long-Jun Wu
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 8.786

6.  SP1-mediated upregulation of LINGO-1 promotes degeneration of retinal ganglion cells in optic nerve injury.

Authors:  Yali Wu; Zongyi Zhan; Yadan Quan; Yangfan Yang; Xiaotao Chen; Liling Liu; Kaili Wu; Minbin Yu
Journal:  CNS Neurosci Ther       Date:  2020-06-19       Impact factor: 7.035

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.